South Rampart Pharma Strengthens Board with Appointment of Ochsner Health CEO Pete November
South Rampart Pharma, Inc. (“South Rampart” or the “Company”), a clinical-stage biotechnology company advancing best-in-class, non-opioid pain therapeutics, today announced the appointment of Pete November, CEO of Ochsner Health, to...